Mode
Text Size
Log in / Sign up

Vaginal hyaluronic acid associated with epithelial transformation in symptomatic benign cervical ectopy

Vaginal hyaluronic acid associated with epithelial transformation in symptomatic benign cervical ect…
Photo by Logan Voss / Unsplash
Key Takeaway
Interpret findings as exploratory; randomized controlled trials are required to determine clinical effectiveness.

This prospective observational study enrolled 121 women diagnosed with symptomatic benign cervical ectopy. The study aimed to assess the specific effects of vaginal hyaluronic acid ovules on epithelial transformation and symptom relief over time.

Participants received vaginal hyaluronic acid ovules (Cicatridine) once daily for 14 days. There was no reported comparator group. The primary outcome showed epithelial transformation rates increased progressively from 61.5% at 4 weeks to 74.6% at 8 weeks and 82.9% at 3 months (p < 0.001). Follow-up assessments occurred at 4 weeks, 8 weeks, and 3 months after treatment. Secondary outcomes included symptom relief, though assessment methods were not standardized.

Safety data regarding adverse events, serious adverse events, discontinuations, and tolerability were not reported in this cohort. Key limitations include the observational design, absence of a control group, and non-standardized symptom assessment. Funding sources and conflicts of interest were not reported.

Clinicians should interpret these findings as exploratory. Further randomized controlled trials are required to determine clinical effectiveness. The association between therapy and transformation should not be overstated regarding symptom relief or clinical effectiveness. Current evidence does not support definitive clinical recommendations.

Study Details

Study typeRct
EvidenceLevel 2
PublishedApr 2026
View Original Abstract ↓
Cervical ectopy is a common physiological condition in women of reproductive age and may be associated with symptoms such as vaginal discharge, postcoital bleeding, dyspareunia, and pelvic pain. While ablative treatments are frequently used in symptomatic cases, interest in non-ablative approaches has increased. This study evaluated clinical and epithelial changes following vaginal hyaluronic acid therapy in women with symptomatic cervical ectopy. This prospective observational study included 121 women diagnosed with symptomatic benign cervical ectopy. All participants received hyaluronic acid vaginal ovules (Cicatridine) once daily for 14 days. Follow-up was performed at 4 weeks, 8 weeks, and 3 months after treatment. Epithelial transformation was assessed by quantifying the extent of columnar epithelium during speculum examination. Temporal changes were analyzed using repeated-measures ANOVA. The mean epithelial transformation rate increased progressively from 61.5% ± 19.8 at 4 weeks to 74.6% ± 21.2 at 8 weeks and 82.9% ± 20.4 at 3 months (p  Vaginal hyaluronic acid therapy was associated with progressive epithelial transformation in women with symptomatic cervical ectopy, with descriptively observed symptom relief. However, because of the observational design, absence of a control group, and non-standardized symptom assessment, these findings should be interpreted as exploratory. Further randomized controlled trials are required to determine clinical effectiveness.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.